Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma

Dewi K Paramita, Jajah Fachiroh, Wayan T Artama, Eric van Benthem, Sofia M Haryana, Jaap M Middeldorp

Research output: Contribution to journalArticleAcademicpeer-review

26 Citations (Scopus)


The Epstein-Barr virus (EBV) early antigen (EA) complex consists of multiple proteins with relevance for diagnosis of acute, chronic and malignant EBV related diseases, including nasopharyngeal carcinoma (NPC). In a recent study, it was found that the molecular diversity of EBV-specific IgG and IgA antibody responses in NPC patients and demonstrated that these reflect independent B-cell triggering leading to distinct EBV antigen-recognition profiles. The fine-specificity of NPC-related IgG and IgA responses was explored further against defined recombinant and synthetic EBV-EA antigens using immunofluorescence, immunoblot and ELISA techniques and determined their diagnostic value in a large panel of sera from NPC (n = 154), non-NPC tumor patients (n = 133), acute mononucleosis patients (n = 70) and healthy EBV carriers (n = 259). Individual recombinant EBV-EA markers yielded sensitivity/specificity values not exceeding 86%, whereas selected EA-specific peptide epitopes were rather poorly recognized by IgG and IgA antibodies in NPC sera. Surprisingly, we found that a "low salt" native EA-protein extract reproducibly prepared from purified nuclei of EA-induced HH514 cells, and containing characteristic EA(D)-polypeptides, such as p47-54 (BMRF1), p138 (BALF2), p55-DNAse (BGLF5), and p65-TK (BXLF1), but without viral capsid (VCA) or nuclear antigen (EBNA) reactivity, gave highest sensitivity (90.4%) and specificity (95.5%) values for NPC diagnosis in both IgG and IgA ELISA. The data support further the notion that EBV-EA reactive IgG and IgA antibodies in NPC patients are directed against distinct conformational and-in part-linear epitopes on EBV-specific proteins, barely recognized in other EBV-related syndromes. The use of a defined native EBV EA-specific antigen opens the way to further improve serological diagnosis of NPC.

Original languageEnglish
Pages (from-to)1710-21
Number of pages12
JournalJournal of Medical Virology
Issue number11
Publication statusPublished - Nov 2007


  • Animals
  • Antigens, Viral
  • Baculoviridae
  • Cell Line
  • Cells, Cultured
  • Enzyme-Linked Immunosorbent Assay
  • Evaluation Studies
  • Herpesvirus 4, Human
  • Humans
  • Immunoglobulin A
  • Immunoglobulin G
  • Journal Article
  • Nasopharyngeal Neoplasms
  • Recombinant Proteins
  • Research Support, Non-U.S. Gov't
  • Spodoptera

Cite this